Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis

A Mohamed Taha, K Abouelmagd… - Frontiers in …, 2024 - frontiersin.org
Background The Vi-diphtheria toxoid typhoid conjugate vaccine (Vi-DT) has shown
promising results in preventing typhoid fever in children under 2 years of age. However, a …

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report

BE Medise, S Soedjatmiko, H Gunardi, R Sekartini… - BMC pediatrics, 2020 - Springer
Background Typhoid fever caused by Salmonella enteric serovar Typhi (S. Typhi) is a
common cause of morbidity in the world. In 2017, 14.3 million cases of Typhoid and …

[HTML][HTML] Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report

MR Capeding, E Alberto, A Sil, T Saluja, S Teshome… - Vaccine, 2020 - Elsevier
Background Typhoid fever remains an important public health problem in developing
countries and is endemic in many parts of Asia and Africa where the incidence of disease …

[PDF][PDF] The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives. Vaccines 2023, 11, 333

V Costanzo, GN Roviello - 2023 - academia.edu
In the modern era, the consumption of antibiotics represents a revolutionary weapon against
several infectious diseases, contributing to the saving of millions of lives worldwide …

One-month follow up of a randomized clinical trial-phase II study in 6 to< 24 months old Indonesian subjects: safety and immunogenicity of vi-DT typhoid conjugate …

BE Medise, S Soedjatmiko, H Gunardi… - International Journal of …, 2020 - Elsevier
Abstract Introduction World Health Organization estimates the annual global incidence of
typhoid fever at 11-21 million cases and approximately 128 000 to 161 000 deaths. The …

[PDF][PDF] Personal Hygiene Dengan Kejadian Demam Tifoid

A Betan, B Badaruddin, F Fatmawati - Jurnal Ilmiah Kesehatan Sandi …, 2022 - core.ac.uk
Metode Desain penelitian kuantitatif dengan pendekatan deskriptif analitis dengan
rancangan Cross Sectional Study yaitu rancangan penelitian yang bertujuan untuk …

A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity

S Koesnoe, BE Medise, I Rengganis… - … , Travel Medicine and …, 2024 - Springer
Background Typhoid fever is commonly found until today, especially in developing
countries. It has fatal complications and measures must be taken to reduce the incidence of …

Penatalaksanaan Holistik pada Pasien Anak dengan Demam Tifoid Melalui Pendekatan Kedokteran Keluarga

AN Sari - Medical Profession Journal of Lampung, 2020 - journalofmedula.com
Typhoid fever is an infectious disease caused by Salmonella typhi. Transmission of the
disease is usually through contaminated food or water. Poor hygiene and healthy behavior …

[HTML][HTML] Transcutaneous vaccination with conjugate typhoid vaccine Vi-DT induces systemic, mucosal, and memory anti-polysaccharide responses

MS Bhuiyan, A Kalsy, M Arifuzzaman… - The American Journal …, 2020 - ncbi.nlm.nih.gov
Transcutaneous vaccination can induce both mucosal and systemic immune responses.
However, there are few data on anti-polysaccharide responses following transcutaneous …

Persistence of antibody after a Vi-tetanus toxoid conjugate vaccine and effect of boosting with a plain polysaccharide vaccine on Vi antibody and antigen-specific B …

T Bentley, E Jones, C Jin, M Moore… - Frontiers in Tropical …, 2021 - frontiersin.org
Background Salmonella enterica serovar Typhi is estimated to cause 9 to 13 million cases of
typhoid fever annually. Typhoid conjugate vaccines represent a promising prophylactic …